The global cataract surgery device market is experiencing an impressive growth trajectory, with projections indicating an increase from USD 8,928 million in 2024 to an estimated USD 12,472.70 million by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of 3.40%, reflecting a dynamic shift in the landscape of cataract treatment, driven by technological advancements and evolving surgical techniques.
Cataracts remain the leading cause of vision impairment worldwide, impacting millions of lives every year. However, the latest innovations in cataract surgery devices are reshaping the way these conditions are treated, enabling patients to achieve better outcomes. Phacoemulsification and femtosecond laser-assisted cataract surgery are just a few examples of cutting-edge techniques that have revolutionized the field, enhancing surgical precision, improving recovery times, and expanding treatment options for patients globally.
“Advancements in cataract surgery technologies, including the integration of femtosecond lasers and premium intraocular lenses (IOLs), are not only enhancing surgical outcomes but also transforming patient experiences,” said FMI. “These innovations allow surgeons to deliver more precise treatments and improve the visual outcomes for patients, ensuring that cataract surgery remains one of the most successful procedures in modern medicine.”
However, the industry faces several challenges that must be addressed to fully capitalize on this growth. One key issue is the high cost of advanced cataract surgery devices and premium IOLs, which limit access to these treatments in emerging economies and underserved regions. As a result, many patients in these areas are unable to benefit from the latest advancements.
In addition, stringent regulatory processes continue to pose hurdles for manufacturers aiming to introduce innovative products to the market. These obstacles can delay the availability of new technologies and limit options for patients in need.
Despite these hurdles, the outlook for the cataract surgery device market remains positive. By addressing concerns such as cost barriers, post-operative complications, and regulatory challenges, the industry has the potential to significantly improve vision care for individuals around the world.
The next decade holds exciting opportunities for continued innovation in cataract surgery, with the promise of even greater precision, safety, and accessibility in cataract treatments for millions of people across the globe.
“There is a growing demand for minimally invasive surgical techniques and micro-incision cataract surgery (MICS), which offer faster recovery times and reduced risk of complications for patients.” Says an FMI Analyst.
Key Takeaways from the Market Study:
- In the cataract surgery device market, intraocular lenses (IOL) dominate the segment, holding around 46.80% of the market share in 2024.
- Nuclear sclerotic cataracts represent the largest application segment in 2024, expected to hold approximately 38.40% market share.
- The United States maintains a moderate CAGR of 1.50% through 2034 in its mature cataract surgery device sector.
- The United Kingdom occupies a distinct market niche with a CAGR of 2.70% through 2034 in its cataract surgery device market.
- Germany’s cataract surgery device market shows stability with a CAGR of 2.90% through 2034, emphasizing efficiency and advanced customer care.
- India exhibits stable demand for cataract surgery devices, with a CAGR of 4.90% through 2034.
- Thailand’s healthcare system advancement drives demand for cataract surgery devices, reflected in a steady 3.70% CAGR through 2034.
Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!
Competition Outlook of the Cataract Surgery Device Market:
The cataract surgery device industry is witnessing intense competition driven by technological advancements, increasing demand for minimally invasive procedures, and a growing aging population globally. Key players in the industry are focusing on innovation to develop advanced devices that offer enhanced safety, efficacy, and patient outcomes. Additionally, strategic collaborations, mergers, and acquisitions are becoming prevalent as companies aim to strengthen their market position and expand their product portfolios.
Several leading companies, such as Alcon, Johnson & Johnson, and Bausch + Lomb, are actively investing in research and development to introduce cutting-edge cataract surgery devices. These devices include phacoemulsification equipment, intraocular lenses (IOLs), femtosecond lasers, and ophthalmic viscoelastic devices (OVDs). Moreover, companies are leveraging advancements in technology, such as artificial intelligence and robotics, to develop next-generation devices that offer precision and efficiency in cataract surgery procedures.
Regional markets play a significant role in shaping the competitive landscape of the cataract surgery device industry. While developed regions like North America and Europe have well-established healthcare infrastructures and high adoption rates of advanced surgical techniques, emerging economies in the Asia Pacific and Latin America are witnessing rapid growth due to improving healthcare facilities and increasing healthcare expenditure. As a result, multinational companies are focusing on expanding their presence in these regions through strategic partnerships with local distributors and healthcare providers to capitalize on the growing demand for cataract surgery devices.
Recent Developments:
- ZEISS Medical Technology presented new ocular advances in the cataract and corneal refractive workflows during the European Society of Cataract and Refractive Surgery (ESCRS) annual meeting, which took place in Vienna, Austria, from September 8 to 12, 2023.
- Johnson & Johnson MedTech, headquartered in the United States, stated on February 15, 2024, that its Vision unit has made the Tecnis PureSee lens accessible in the EMEA market.
- Alcon, a global pioneer in eye care, presented a powerful array of scientific data at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held from September 8 to 12.
- Bausch + Lomb, a Canadian eye health firm, has released the StableVisc cohesive ophthalmic viscosurgical device (OVD) and TotalVisc Viscoelastic System in the United States. The two new OVDs, StableVisc OVD and TotalVisc, offered eye doctors new ways to provide dual-action protection during cataract surgery.
- EyeCare Partners (ECP), a premier provider of clinically integrated eye care in the United States, announced the introduction of its new Advanced Comprehensive Ophthalmology Fellowship (ACOF).
Key Companies in the Market:
- Carl Zeiss Meditech AG
- Bausch & Lomb Inc.
- Alcon Incorporated
- NIDEK Co. Ltd.
- Essilor International S.A.
Key Segments:
By Product Type:
- Phacoemulsification Equipment
- Ophthalmic Viscoelastic Devices (OVD)
- Femtosecond Lasers
- Intraocular Lens (IOLs)
By Application:
- Posterior Sub-capsular Cataracts
- Cortical Cataracts
- Nuclear Sclerotic Cataracts
- Congenital Cataracts
- Traumatic Cataracts
- Others
By End User:
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgery Centers
- Online Sales
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube